Boston Scientific (BSX) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Goldman Sachs Upgrades Boston Scientific (BSX) to Neutral
October 23, 2014 6:44 AM EDTGoldman Sachs upgraded Boston Scientific (NYSE: BSX) from Sell to Neutral with a price target of $13.00 (from $11.00).
Analyst David H. Roman said, "We upgrade shares of Boston Scientific (BSX) to Neutral from Sell, given what looks to be higher sustainable growth and more... More
Benchmark Upgrades Boston Scientific (BSX) to Buy
October 22, 2014 2:17 PM EDTBenchmark upgraded Boston Scientific (NYSE: BSX) from Hold to Buy with a price target of $15.00.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
Shares of Boston Scientific closed at $12.03 yesterday.
... More


